News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Quintiles, Inc. (QTRN) Backs Change to Marketing Mix as NHS Reforms Take Hold


6/12/2012 10:26:51 AM

READING, United Kingdom--(BUSINESS WIRE)--Quintiles has released the first in a series of briefing papers looking at how market access strategies can help biopharma navigate the risk of commercialising their drugs in the context of healthcare reform across Europe.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES